Thank you for correcting the text in this article. Your corrections improve Papers Past searches for everyone. See the latest corrections.

This article contains searchable text which was automatically generated and may contain errors. Join the community and correct any errors you spot to help us improve Papers Past.

Article image
Article image
Article image
Article image

SPAHLINGER SERUM

SIR DONALD McGAVIN IMPRESSED. FAIR EXPENDITURE JUSTIFIED. (Per United Press Association.) WELLINGTON, December 13. Sir Donald McGavin, formerly DirectorGeneral of Medical Services in the New Zealand Defence Department, who returned to Wellington yesterday from a tour of Europe, discussing the Spahlinger treatment for consumption, said there was sufficient evidence in favour of the treatment to justify the expenditure of a fair sum in acquiring material for treatment to be carried out in the Dominion. It should be made clear, however, that the evidence was not complete in its scientific requirements, i.e., accurate cases of records before, during and after treatment were not available, except in a few cases. There was written evidence of competent authorities who visited the Spahlinger laboratory, including French, British and other medical men. Continuing, Sir Donald McGavin said the attitude of medical men towards the treatment had been construed as narrow-minded, which was quite unfair in view of the incomplete state of the investigation. If the preparation was only a fraction as valauble as Spahlinger and others claimed it to be the money devoted to its development would be profitably expended.

Permanent link to this item

https://paperspast.natlib.govt.nz/newspapers/ST19231214.2.41

Bibliographic details

Southland Times, Issue 19122, 14 December 1923, Page 5

Word Count
187

SPAHLINGER SERUM Southland Times, Issue 19122, 14 December 1923, Page 5

SPAHLINGER SERUM Southland Times, Issue 19122, 14 December 1923, Page 5

Help

Log in or create a Papers Past website account

Use your Papers Past website account to correct newspaper text.

By creating and using this account you agree to our terms of use.

Log in with RealMe®

If you’ve used a RealMe login somewhere else, you can use it here too. If you don’t already have a username and password, just click Log in and you can choose to create one.


Log in again to continue your work

Your session has expired.

Log in again with RealMe®


Alert